A new study from the US finds that use of aspirin is tied to a reduced risk for hepatocellular carcinoma, the most common type of primary liver cancer, and also to a reduced risk of death from chronic liver disease. Vikrant V. Sahasrabuddhe, from the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, and colleagues, write about their findings in the 28 November online issue of the Journal of the National Cancer Institute, JNCI. Hepatocellular carcinoma occurs mainly in people with chronic liver disease...
More...
More...